Ypsomed
Compare Ypsomed…Swiss drug-delivery device maker. Primary autoinjector pen supplier to Novo Nordisk for Wegovy and Ozempic. Pen business growing on GLP-1 pen attach.
SectorsGLP-1
Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Ypsomed (YPSN.SW) is a medical devices company based in Burgdorf, Switzerland. In Q1 2026, it reported revenue of $416.00M.
YpsomedSwiss drug-delivery device maker. Primary autoinjector pen supplier to Novo Nordisk for Wegovy and Ozempic. Pen business growing on GLP-1 pen attach.
Q2 2016-Q1 2026
Q2 2016-Q1 2026
Q2 2016-Q1 2026
Ypsomed (YPSN.SW) is a Medical Devices company. Swiss drug-delivery device maker. Primary autoinjector pen supplier to Novo Nordisk for Wegovy and Ozempic. Pen business growing on GLP-1 pen attach. It was founded in 1984, is headquartered in Burgdorf, Switzerland and employs about 2,400 people.
Track Ypsomed's quarterly and annual revenue, gross and net margins, and EPS in the interactive charts on this page. Data last updated July 24, 2026.
Sterling groups Ypsomed in the GLP-1 sector, alongside Eli Lilly (LLY), Novo Nordisk (NVO), Pfizer (PFE), Amgen (AMGN), Roche (RHHBY) and AstraZeneca (AZN).
If you are researching Ypsomed, also look at Eli Lilly (LLY), Novo Nordisk (NVO) and Pfizer (PFE). You can compare all of them side by side or browse the full GLP-1 sector on Sterling.